Geneos Wealth Management’s argenx ARGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-57
Closed -$31.4K – 2516
2025
Q2
$31.4K Sell
57
-60
-51% -$34.8K ﹤0.01% 1813
2025
Q1
$69.2K Buy
117
+99
+550% +$62.5K ﹤0.01% 1319
2024
Q4
$11.1K Buy
18
+14
+350% +$8.2K ﹤0.01% 2011
2024
Q3
$2.17K Buy
+4
New +$2.02K ﹤0.01% 2282
2024
Q2
– Sell
-9
Closed -$3.54K – 2062
2024
Q1
$3.54K Buy
+9
New +$3.49K ﹤0.01% 1781
2023
Q4
– Sell
-2
Closed -$983 – 2099
2023
Q3
$983 Buy
+2
New +$978 ﹤0.01% 2030

Other funds holding ARGX

Geneos Wealth Management's ARGX Position: Q3 2025 in Review

Geneos Wealth Management sold out of argenx (ARGX) in Q3 2025, closing a stake of 57 shares — an estimated $31.4K sold.

Geneos Wealth Management first reported a position in ARGX in Q3 2023 and held it in 6 quarters. The position peaked at $69.2K in Q1 2025. 469 funds tracked by Wall St. Rank hold ARGX as of Q3 2025.

  • Geneos Wealth Management reported no remaining argenx position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 57 argenx shares in Q3 2025, an estimated $31.4K.
  • Geneos Wealth Management first reported a position in argenx in Q3 2023 and held it in 6 quarters.
  • Geneos Wealth Management's argenx position peaked at $69.2K in Q1 2025.
  • 469 funds tracked by Wall St. Rank held argenx as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.